UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
BMS to test cabiralizumab+nivolumab for pancreatic cancer
Bristol-Myers Squibb is soon to conduct phase-2 trials in Korea on its immu...
by Lee Hye-seon
|
2018-10-11 14:23
라인
Anticipation grows for Lenvima as new liver cancer drug
Eisai Korea’s Lenvima (lenvatinib), recently approved as a first-line treat...
by Nam Doo-hyun
|
2018-10-11 11:44
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon
|
2018-10-10 15:31
라인
Hanmi unveils test results for asthma-rhinitis combination drug in US
Hanmi said Wednesday that it has presented its phase 3 clinical trial resul...
by Lee Han-soo
|
2018-10-10 12:08
라인
‘Medytox performance depends on Chinese regulations on peddlers’
Medytox’s performance in the fourth quarter will rely on the Chinese govern...
by Nam Doo-hyun
|
2018-10-08 16:59
라인
Abbott’s hepatitis B antibody reagent recalled due to error
The government ordered Korea Abbott to recall its hepatitis B antibody reag...
by Lee Hye-seon
|
2018-10-08 15:52
라인
Amantadine sulfate to lose indication for influenza A virus treatment
The government said it would change approval conditions for two pharmaceuti...
by Lee Hye-seon
|
2018-10-08 15:49
라인
Pharmaceuticals seek fresh start with new CEOs
Several pharmaceutical and biotech firms have appointed a new CEO or a vice...
by So Jae-hyeon
|
2018-10-05 15:44
라인
Allergan’s eye implant recalled due to foreign substance
Allergan is recalling Ozurdex Intravitreal Implant 700㎍ (ingredient: dexame...
by Lee Hye-seon
|
2018-10-05 13:53
라인
Daewoong to refile clinical trial plan on botulinum toxin in China
Daewoong Pharmaceutical has changed its strategy of entering the Chinese ma...
by So Jae-hyeon
|
2018-10-05 12:00
라인
GC LabCell seeks to expand indication of natural killer cell-based therapy
GC LabCell said Thursday it has received regulatory approval for a phase-1/...
by So Jae-hyeon
|
2018-10-04 14:51
라인
BMS to start phase-3 test on oral psoriasis treatment in Korea
Bristol-Myers Squibb said it would begin global phase-3 trials on BMS-98616...
by Lee Hye-seon
|
2018-10-01 15:09
라인
Pharma event to showcase AI-based solutions for new drug development
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) a...
by So Jae-hyeon
|
2018-10-01 13:34
라인
Genexine unveils clinical trial results for persistent growth hormone
Genexine said Friday that it has presented the phase 2 clinical trial resul...
by Lee Han-soo
|
2018-09-28 16:46
라인
Original hypertension drugs enjoy sales growth after valsartan recall
Original hypertension treatments by multinational pharmaceuticals achieved ...
by So Jae-hyeon
|
2018-09-28 15:55
라인
Samil shares jump on anticipation of fatty liver treatment
Shares of Samil Pharmaceutical spiked on Thursday on investors’ anticipatio...
by Nam Doo-hyun
|
2018-09-28 14:21
라인
Ministry approves GC’s influenza vaccine for all ages
GC said Friday that it has received additional approval from the Ministry o...
by Lee Han-soo
|
2018-09-28 14:20
라인
Hanmi’s new diabetes drug to take on Lilly’s in tests
Sanofi said it would begin global phase-3 clinical trials to compare Hanmi ...
by Park Gi-taek
|
2018-09-28 11:32
라인
Dong-A ST ordered to suspend sale of 12 drugs due to illegal rebates
The Ministry of Food and Drug Safety said it has ordered Dong-A ST to suspe...
by Lee Hye-seon
|
2018-09-27 15:33
라인
Genexine wins nod for immunotherapy trial in combo treatment
Pharmaceutical industry officials are pinning high hopes on combination tre...
by Nam Doo-hyun
|
2018-09-27 11:25
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top